Meproscillarin is a glycoside with a high bioavailability (about 70%) and an elimination independent of the renal function. References: Alken RG, Belz GG. A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):634-40. PubMed PMID: 6206318.

纯度：≥98%

CAS：33396-37-1